Press Releases

Three oscillating proteins cause new muscle cells to emerge from muscle stem cells in a balanced manner. In a paper being published in the journal "Nature Communications", a team led by MDC researcher Carmen Birchmeier explains in detail how this process works.

Erich Wanker wants to find out to what extent misfolded, and hence pathological, amyloid proteins structurally alter other proteins in the neurons – and thus contribute to the progression of Alzheimer’s dementia. He has now received €120,000 in funding from the non-profit "Alzheimer Forschung Initiative" to pursue this research.

Cancer cells are quick-change artists. A team led by Gaetano Gargiulo and Michela Serresi of the MDC has investigated in depth the molecular mechanisms that drive this constant metamorphosis. The researchers are now publishing their findings in the journal "Science Advances".

A year ago, BIH, MDC and Charité launched the joint research focus "Single Cell Approaches for Personalised Medicine". Its aim is to use innovative single cell technologies to answer clinical questions. This aspiration will be put into practice by four new junior research groups, which have now started.

Some converse in Creole, while others speak Scots, but it’s not only humans who can be identified by the diversity of language they speak. Naked mole-rats have their own dialects, too. Shared dialect also strengthens cohesion within a colony, a team led by MDC researcher Gary Lewin reports in the current "Science" cover story.

Every year, some 510,000 people in Germany are diagnosed with cancer – and there are over four million people in the country today living with a cancer diagnosis. On the occasion of World Cancer Day on February 4, the Max Delbrück Center for Molecular Medicine (MDC) is giving media representatives an opportunity to hear from experts on the current state of cancer research.

Anton Henssen of the ECRC has been awarded the Kind Philipp Award for Pediatric Oncology Research for his study of ring-shaped DNA and its significance in the development of childhood neuroblastoma. A publication in the scientific journal Nature Genetics was decisive for this award.

MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular lymphomas and chronic lymphocytic leukemia, the most common type of blood cancer in adults.

On January 1, 2021, the Berlin Institute of Health (BIH ) has become the translational research unit of Charité – Universitätsmedizin Berlin and will then form – alongside the hospital and the medical faculty – Charité’s third pillar.

The European Research Council (ERC) awarded Dr. Mina Gouti a €2.8 million Consolidator Grant to further develop miniature neuromuscular organoids for studying neuromuscular development and diseases. It was the second honor in as many weeks; she was also named an EMBO Young Investigator for her work.